PHAT

NASDAQStock

Phathom Pharmaceuticals, Inc.

$10.13-1.03 (-9.29%)

52-Week Range

$2.29
$18.08

Key Stats

Market Cap

798.2M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Volume

963.6K

Avg Volume

1.2M

Performance

1M

-20.28%

3M

-29.81%

6M

-10.98%

YTD

-34.95%

1Y

+104.40%

3Y

+42.94%

5Y

-77.19%

Price Chart

ETF Exposure

PHAT is held by 48 ETFs

ETFFund NameWeight
SURISimplify Propel Opportunities ETF4.24%
XPHState Street SPDR S&P Pharmaceuticals ETF1.28%
BBPVirtus Biotech ETF1.17%
PTHInvesco Dorsey Wright Healthcare Momentum ETF0.58%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.55%
FTKIFirst Trust Small Cap BuyWrite Income ETF0.27%
PILLDirexion Daily Pharmaceutical & Medical Bull 3X ETF0.25%
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.17%
IHEiShares U.S. Pharmaceuticals ETF0.13%
VFMOVanguard U.S. Momentum Factor ETF0.12%
IWCiShares Micro-Cap ETF0.09%
IBBQInvesco Nasdaq Biotechnology ETF0.06%
IBBiShares Biotechnology ETF0.04%
BIBProShares - Ultra Nasdaq Biotechnology0.04%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.03%
VTWVVanguard Russell 2000 Value ETF0.03%
IWNiShares Russell 2000 Value ETF0.02%
NUSCNuveen ESG Small-Cap0.02%
VTWOVanguard Russell 2000 ETF0.02%
IWMiShares Russell 2000 ETF0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
SCHASchwab U.S. Small-Cap ETF0.01%
UWMProShares - Ultra Russell20000.01%
URTYProShares - UltraPro Russell20000.01%
VHTVanguard Health Care ETF0.01%
VTWGVanguard Russell 2000 Growth ETF0.01%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.01%
VXFVanguard Extended Market ETF0.01%
WSMLiShares MSCI World Small-Cap ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
AVUQAvantis U.S. Quality ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%

About PHAT ETF Exposure

Phathom Pharmaceuticals, Inc. (PHAT) is held by 48 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 798.2M, PHAT is a widely held institutional stock. The stock currently trades at $10.13. Investors can gain exposure to PHAT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PHAT, sorted by portfolio weight.